Preparation and In Vitro Release of Drug-Loaded Microparticles for Oral Delivery Using Wholegrain Sorghum Kafirin Protein

Figure 2

In vitro drug release profile of a commercially available 5 mg prednisolone tablet compared to prednisolone release from the three different types of kafirin microparticles containing 5 mg prednisolone. Prednisolone release was measured in conditions simulating the stomach for 1 h, followed by the small intestine for 6 h, (a) without enzymes and (b) in the presence of the enzymes pepsin and pancreatin. Values are mean ± SEM ().

(a)

(b)